1. Home
  2. VRAX vs XELB Comparison

VRAX vs XELB Comparison

Compare VRAX & XELB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRAX
  • XELB
  • Stock Information
  • Founded
  • VRAX 2013
  • XELB 2011
  • Country
  • VRAX United Kingdom
  • XELB United States
  • Employees
  • VRAX N/A
  • XELB N/A
  • Industry
  • VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • XELB Multi-Sector Companies
  • Sector
  • VRAX Health Care
  • XELB Miscellaneous
  • Exchange
  • VRAX Nasdaq
  • XELB Nasdaq
  • Market Cap
  • VRAX 4.7M
  • XELB 4.6M
  • IPO Year
  • VRAX 2022
  • XELB N/A
  • Fundamental
  • Price
  • VRAX $0.79
  • XELB $1.81
  • Analyst Decision
  • VRAX Strong Buy
  • XELB
  • Analyst Count
  • VRAX 1
  • XELB 0
  • Target Price
  • VRAX $3.00
  • XELB N/A
  • AVG Volume (30 Days)
  • VRAX 38.7K
  • XELB 145.6K
  • Earning Date
  • VRAX 02-05-2025
  • XELB 08-13-2025
  • Dividend Yield
  • VRAX N/A
  • XELB N/A
  • EPS Growth
  • VRAX N/A
  • XELB N/A
  • EPS
  • VRAX N/A
  • XELB N/A
  • Revenue
  • VRAX $84,872.00
  • XELB $7,407,000.00
  • Revenue This Year
  • VRAX $5,169.18
  • XELB $23.96
  • Revenue Next Year
  • VRAX $66.97
  • XELB $53.02
  • P/E Ratio
  • VRAX N/A
  • XELB N/A
  • Revenue Growth
  • VRAX 7.03
  • XELB N/A
  • 52 Week Low
  • VRAX $0.74
  • XELB $1.60
  • 52 Week High
  • VRAX $9.00
  • XELB $8.49
  • Technical
  • Relative Strength Index (RSI)
  • VRAX 31.75
  • XELB 38.69
  • Support Level
  • VRAX $0.75
  • XELB $1.60
  • Resistance Level
  • VRAX $0.85
  • XELB $2.06
  • Average True Range (ATR)
  • VRAX 0.07
  • XELB 0.17
  • MACD
  • VRAX -0.01
  • XELB 0.01
  • Stochastic Oscillator
  • VRAX 6.57
  • XELB 42.00

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.

About XELB Xcel Brands Inc.

Xcel Brands Inc is a media and brand management company. It is engaged in design, merchandising and planning, sourcing and production, licensing, marketing, and brand development. The company offers branded apparel, footwear, accessories, jewelry, home goods, and other consumer products. Its brand portfolio consists of the Isaac Mizrahi, Judith Ripka, H Halston, C Wonder, and the Highline Collective brands. The company licenses its brands to third parties, provides certain designs, production, and marketing services, and generates licensing, design, and service fee revenues through contractual arrangements and other agreements.

Share on Social Networks: